首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Gene therapy: progress and predictions
Authors:Mary Collins  Adrian Thrasher
Institution:1.Division of Infection and Immunity, University College London, Gower Street, London WC1E 6BT, UK;2.Institute of Child Health, University College London, Gower Street, London WC1E 6BT, UK;3.Division of Advanced Therapies, National Institute for Biological Standards and Control, Blanche Lane, Potters Bar, Herts EN6 3QG, UK
Abstract:The first clinical gene delivery, which involved insertion of a marker gene into lymphocytes from cancer patients, was published 25 years ago. In this review, we describe progress since then in gene therapy. Patients with some inherited single-gene defects can now be treated with their own bone marrow stem cells that have been engineered with a viral vector carrying the missing gene. Patients with inherited retinopathies and haemophilia B can also be treated by local or systemic injection of viral vectors. There are also a number of promising gene therapy approaches for cancer and infectious disease. We predict that the next 25 years will see improvements in safety, efficacy and manufacture of gene delivery vectors and introduction of gene-editing technologies to the clinic. Gene delivery may also prove a cost-effective method for the delivery of biological medicines.
Keywords:gene therapy  evolutionary medicine  personalized medicine
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号